0.019
-0.0015 (-7.32%)
-0.0015 (-7.32%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immune Therapeutics Inc (PK) | IMUN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0015 | -7.32% | 0.019 | 16:17:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0205 | 0.017 | 0.0205 | 0.019 | 0.0205 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.015 | 0.019 | 0.004 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 47 | 5,393,791 | $ 0.01802 | $ 97,196 | - | 0.0056 - 0.0499 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:48:07 | 5,000 | $ 0.019 | USD |
Immune Therapeutics (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 9.05M | 476.50M | 7.99M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 86.10k | $ - | 0.00% | - | - |
Immune Therapeutics (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0275 | 0.029 | 0.017 | 0.0223258 | 2,562,646 | -0.0085 | -30.91% |
| 1 Month | 0.01655 | 0.0327 | 0.0164 | 0.0232421 | 2,552,474 | 0.00245 | 14.8% |
| 3 Months | 0.016775 | 0.0327 | 0.0128 | 0.0197384 | 1,814,456 | 0.00223 | 13.26% |
| 6 Months | 0.01995 | 0.0489 | 0.0112 | 0.0237282 | 2,689,120 | -0.00095 | -4.76% |
| 1 Year | 0.0073 | 0.0499 | 0.0056 | 0.0209378 | 2,287,430 | 0.0117 | 160.27% |
| 3 Years | 0.0266 | 0.0499 | 0.0027 | 0.017793 | 1,194,586 | -0.0076 | -28.57% |
| 5 Years | 0.165 | 0.20 | 0.0027 | 0.0274292 | 989,562 | -0.146 | -88.48% |
Immune Therapeutics (PK) Description
| Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. |
